← FDA Drug Approvals (Drugs@FDA)

KEPPRA XR

NDA · New Drug Application · Sponsor: UCB INC · Approved 2008-09-12

Drug application

FDA Application #

NDA022285

Application type

New Drug Application

Brand name

KEPPRA XR

Generic name

LEVETIRACETAM

Active ingredients

LEVETIRACETAM

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

UCB INC

Manufacturer

UCB, Inc.

First approval

2008-09-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown